Reversal of μ-opioid-mediated respiratory depression by α2-adrenoceptor antagonism
- 31 December 1991
- journal article
- Published by Elsevier in Life Sciences
- Vol. 49 (2) , 111-119
- https://doi.org/10.1016/0024-3205(91)90024-6
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The effect of medetomidine, an α2-adrenoceptor agonist, in various pain testsEuropean Journal of Pharmacology, 1990
- Minireview: Multiple MU opiate receptorsLife Sciences, 1986
- Autoradiographic analysis of mu1, mu2, and delta opioid binding in the central nervous system of C57BL/6BY and CXBK (opioid receptor-deficient) miceBrain Research, 1985
- Morphine catalepsy in the rat: Involvement of μ1 (high affinity) opioid binding sitesNeuroscience Letters, 1982
- Morphine analgesia in the tail-flick and Formalin pain tests is mediated by different neural systemsExperimental Neurology, 1982
- Direct evidence that spinal serotonin and noradrenaline terminals mediate the spinal antinociceptive effects of morphine in the periaqueductal grayBrain Research, 1979
- Catecholaminergic depressant effects on bulbar respiratory mechanismsBrain Research, 1979
- Narcotic analgetics: CNS sites and mechanisms of action as revealed by intracerebral injection techniquesPain, 1977
- Possible involvement of central adrenaline neurons in vasomotor and respiratory control. Studies with clonidine and its interactions with piperoxane and yohimbineEuropean Journal of Pharmacology, 1974
- Pharmacological studies on a possible role of central noradrenaline neurons in respiratory controlJournal of Pharmacy and Pharmacology, 1973